Hosted on MSN14m
Halted research, disciplined doctors: internal audit finds Kaiser ignored patient protections in Northern California study
Many of modern medicine's most remarkable achievements have been accomplished through the trust of volunteers, who test new drugs, procedures and medical devices to determine if they are safe and ...
Sorbet Recall Update As FDA Sets Highest Risk Level
A sorbet-filled mochi recalled due to an undeclared allergen has been given the U.S. Food and Drug Administration (FDA)'s ...
Takeaways from RFK Jr.'s first confirmation hearing as Trump’s nominee for health secretary
Robert F. Kennedy Jr., was pressed to clarify his views on vaccines, abortion and public health priorities in the first of ...
Catholic News Agency1h
Pro-abortion group’s study finds ingredient in morning-after pill can induce abortion
The active ingredient is used in the morning-after pill commonly marketed as “ella” or “ellaOne,” which is advertised as a ...
Kennedy says he will finalize rules that increase diversity in clinical trials
Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, told U.S. senators during his ...
Kennedy Says Ultraprocessed Foods Are Driving Chronic Disease. Here’s What the Science Shows.
In a Senate hearing, Robert F. Kennedy, Jr. said that efforts to address the high rates of chronic disease need to start with ...
RFK JR. grilled on Medicare: What is Medicare Part A, Medicare Part B and Medicaid? What are they?
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
Lay’s potato chip recall elevated to FDA’s highest-risk classification
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
Live updates: RFK Jr. faces opposition from senators in fiery confirmation hearing
Trump's pick for HHS Secretary faces questions from the left and right over his health stances. But will that stop his ...
Teva's Growth Profile Looks Strong From Innovative Portfolio, Biosimilar Approvals and Deep Pipeline
We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic ...
federalnewsnetwork.com2h
FDA’s accelerated approval pathway has a few potholes
The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.